Gynecological cancers affect a growing number of women globally, with approximately 1.3
million women diagnosed in 2018. Menopausal symptoms are a significant health concern …

Background Serious and potentially life-threatening toxicities can occur following 5-
fluorouracil/capecitabine exposure. Patients carrying Dihydropyrimidine Dehydrogenase …

More than 6 million women worldwide are living with a past diagnosis of breast cancer. Most
survive their illness, and management of the long-term consequences of treatment has …

The changing landscape of gynaecological and breast cancers has involved the
development of more targeted and effective therapies, and improved survival. Ultimately …

The efficacy of menopausal hormone therapy for bothersome menopausal symptoms is well
established. However, there are a range of benign and malignant gynaecological conditions …

Botulinum toxin, from the bacteria Clostridium botulinum, acts by block the pre-synaptic
release of acetylcholine at the neuromuscular junction, resulting in temporary muscle …

Haematopoietic stem cell transplants are an important treatment for haematological
malignancies. With increasing efficacy of treatment, it has become important to provide …

Abnormal uterine bleeding refers to any change in the regularity, frequency, heaviness or
length of menstruation. There are several potential causes for bleeding disturbance, the two …

The global incidence of breast cancer is increasing, as is the efficacy of treatments.
Consequently, increasing survival rates reinforce the importance of survivorship issues …

The menopause transition can be a challenging time for women, bringing about changes in
physical wellbeing, including vasomotor symptoms, sleep disturbance and vaginal dryness …